Bhandari Hosiery Exports Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 2, 2025, 1:18 am

Competitors of Bhandari Hosiery Exports Ltd

All Competitor Stocks of Bhandari Hosiery Exports Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:55 pm

Below is a detailed analysis of the quarterly data for Bhandari Hosiery Exports Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 62.91 Cr.. The value appears to be declining and may need further review. It has decreased from 89.23 Cr. (Mar 2025) to 62.91 Cr., marking a decrease of 26.32 Cr..
• For Expenses, as of Jun 2025, the value is 56.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 81.80 Cr. (Mar 2025) to 56.50 Cr., marking a decrease of 25.30 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.41 Cr.. The value appears to be declining and may need further review. It has decreased from 7.43 Cr. (Mar 2025) to 6.41 Cr., marking a decrease of 1.02 Cr..
• For OPM %, as of Jun 2025, the value is 10.19%. The value appears strong and on an upward trend. It has increased from 8.33% (Mar 2025) to 10.19%, marking an increase of 1.86%.
• For Other Income, as of Jun 2025, the value is 0.06 Cr.. The value appears to be declining and may need further review. It has decreased from 0.15 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.09 Cr..
• For Interest, as of Jun 2025, the value is 2.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.72 Cr. (Mar 2025) to 2.58 Cr., marking a decrease of 0.14 Cr..
• For Depreciation, as of Jun 2025, the value is 1.73 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.70 Cr. (Mar 2025) to 1.73 Cr., marking an increase of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.16 Cr.. The value appears to be declining and may need further review. It has decreased from 3.16 Cr. (Mar 2025) to 2.16 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 16.14% (Mar 2025) to 25.00%, marking an increase of 8.86%.
• For Net Profit, as of Jun 2025, the value is 1.62 Cr.. The value appears to be declining and may need further review. It has decreased from 2.65 Cr. (Mar 2025) to 1.62 Cr., marking a decrease of 1.03 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.07. The value appears to be declining and may need further review. It has decreased from 0.11 (Mar 2025) to 0.07, marking a decrease of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:28 pm

Growth

Last Updated: September 5, 2025, 12:50 am

Balance Sheet

Last Updated: August 11, 2025, 1:44 pm

Below is a detailed analysis of the balance sheet data for Bhandari Hosiery Exports Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 46.00 Cr..
• For Borrowings, as of Mar 2025, the value is 102.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 122.00 Cr. (Mar 2024) to 102.00 Cr., marking a decrease of 20.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing). It has decreased from 29.00 Cr. (Mar 2024) to 20.00 Cr., marking a decrease of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 251.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 25.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2024) to 74.00 Cr., marking a decrease of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 202.00 Cr.. The value appears strong and on an upward trend. It has increased from 172.00 Cr. (Mar 2024) to 202.00 Cr., marking an increase of 30.00 Cr..
• For Total Assets, as of Mar 2025, the value is 276.00 Cr.. The value appears strong and on an upward trend. It has increased from 251.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 25.00 Cr..

Notably, the Reserves (129.00 Cr.) exceed the Borrowings (102.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bhandari Hosiery Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.42 (Mar 24) to 0.32, marking a decrease of 0.10.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 5. It has decreased from 0.40 (Mar 24) to 0.36, marking a decrease of 0.04.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 3. It has decreased from 0.73 (Mar 24) to 0.60, marking a decrease of 0.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.38. It has increased from 6.09 (Mar 24) to 6.38, marking an increase of 0.29.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.38. It has increased from 6.09 (Mar 24) to 6.38, marking an increase of 0.29.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 1. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.60. It has decreased from 16.32 (Mar 24) to 11.60, marking a decrease of 4.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 2. It has decreased from 1.55 (Mar 24) to 1.18, marking a decrease of 0.37.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.89. This value is within the healthy range. It has decreased from 1.22 (Mar 24) to 0.89, marking a decrease of 0.33.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.53 (Mar 24) to 0.42, marking a decrease of 0.11.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 2. It has decreased from 0.39 (Mar 24) to 0.32, marking a decrease of 0.07.
• For PBDIT Margin (%), as of Mar 25, the value is 10.20. This value is within the healthy range. It has increased from 9.51 (Mar 24) to 10.20, marking an increase of 0.69.
• For PBIT Margin (%), as of Mar 25, the value is 7.73. This value is below the healthy minimum of 10. It has increased from 7.47 (Mar 24) to 7.73, marking an increase of 0.26.
• For PBT Margin (%), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 10. It has increased from 3.27 (Mar 24) to 3.65, marking an increase of 0.38.
• For Net Profit Margin (%), as of Mar 25, the value is 2.76. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 24) to 2.76, marking an increase of 0.32.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.03. This value is below the healthy minimum of 15. It has decreased from 6.56 (Mar 24) to 5.03, marking a decrease of 1.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.76. This value is within the healthy range. It has decreased from 13.53 (Mar 24) to 11.76, marking a decrease of 1.77.
• For Return On Assets (%), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has increased from 2.60 (Mar 24) to 2.79, marking an increase of 0.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.38 (Mar 24) to 0.13, marking a decrease of 0.25.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.63. This value is within the healthy range. It has decreased from 1.17 (Mar 24) to 0.63, marking a decrease of 0.54.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. It has decreased from 1.14 (Mar 24) to 1.06, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.65 (Mar 24) to 2.16, marking an increase of 0.51.
• For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has increased from 0.81 (Mar 24) to 1.26, marking an increase of 0.45.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.31. This value is below the healthy minimum of 4. It has increased from 2.44 (Mar 24) to 3.31, marking an increase of 0.87.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.22. This value is below the healthy minimum of 20. It has increased from 2.24 (Mar 24) to 6.22, marking an increase of 3.98.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 20. It has increased from 1.22 (Mar 24) to 3.29, marking an increase of 2.07.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.78. This value exceeds the healthy maximum of 70. It has decreased from 97.76 (Mar 24) to 93.78, marking a decrease of 3.98.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.71. This value exceeds the healthy maximum of 70. It has decreased from 98.78 (Mar 24) to 96.71, marking a decrease of 2.07.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 3. It has increased from 2.27 (Mar 24) to 2.50, marking an increase of 0.23.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.68. This value is below the healthy minimum of 3. It has increased from 1.58 (Mar 24) to 1.68, marking an increase of 0.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 210.64. It has decreased from 236.05 (Mar 24) to 210.64, marking a decrease of 25.41.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 24) to 0.75, marking a decrease of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is 7.41. This value is within the healthy range. It has decreased from 9.30 (Mar 24) to 7.41, marking a decrease of 1.89.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has decreased from 0.44 (Mar 24) to 0.40, marking a decrease of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 93.77. This value exceeds the healthy maximum of 70. It has decreased from 97.75 (Mar 24) to 93.77, marking a decrease of 3.98.
• For Price / BV (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.74, marking a decrease of 0.46.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has decreased from 0.44 (Mar 24) to 0.40, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness